Search results
Results from the WOW.Com Content Network
Harbor Freight Tools won a declassification of the class action; that is, the court found that all the individual situations were not similar enough to be judged as a single class, and that their claims would require an individual-by-individual inquiry, so the case could not be handled on a class basis.
The FDA has recalled 28 beverages so far in 2024, The Daily Mail reported. All but four of the drinks were recalled because they had drugs, bacteria or harmful chemicals in them that the company ...
On November 6, the U.S. Food & Drug Administration issued a recall on Diet Coke, Sprite, and Fanta Orange sold in three states due to a "potential foreign material." United Packers, LLC initiated ...
The recall affects four of the company's drinks: Pink Lemonade, Cola Flavoring Base, Yellow Lemonade, and Yellow Lemonade X. These beverages, sold in 1- and 5-gallon quantities, are distributed to ...
This policy was later challenged in court following FDA approval of a food coloring manufactured with a compound known to be carcinogenic, after separate testing indicated that the food coloring itself did not cause cancer in test animals. The United States Court of Appeals for the Sixth Circuit upheld the FDA's approval of the food coloring. [36]
An Emergency Use Authorization (EUA) in the United States is an authorization granted to the Food and Drug Administration (FDA) under sections of the Federal Food, Drug, and Cosmetic Act as added to and amended by various Acts of Congress, including by the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), as codified by 21 U.S.C. § 360bbb-3, to allow the use of a ...
The FDA has removed the following items from store shelves this September, including pet food, baby powder and Lactaid. Skip to main content. 24/7 Help. For premium support please call: 800-290 ...
The Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA) is a piece of American regulatory legislation signed into law on July 9, 2012.It gives the United States Food and Drug Administration (FDA) the authority to collect user fees from the medical industry to fund reviews of innovator drugs, medical devices, generic drugs and biosimilar biologics.